Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.

This article originally appeared here.
Share this content:
Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.
Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.

(HealthDay News) -- In the United States, Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower death rates than whites, blacks, or Native Americans with the disease, according to a study published online Jan. 15 in Arthritis & Rheumatology.

Researchers reviewed Medicaid claims filed by 42,221 SLE patients, aged 18 to 65, between 2000 and 2006. Of those patients, 8,191 had lupus nephritis.

By racial/ethnic group, the percentages of patients with SLE or lupus nephritis were: black, 40 percent; white, 38 percent; Hispanic, 15 percent; Asian, 5 percent; and Native American, 2 percent. Hispanic and Asian SLE patients had the lowest death rates. The annual death rate was highest among Native Americans, blacks, and whites, in that order.

"In less than three years of follow-up of Medicaid patients with lupus, we found a great disparity in mortality rates among ethnic groups. Understanding the variation of death among the races is important to determine how best to treat individual patients, modify risk factors, and ultimately improve survival for those with lupus," lead author José Gómez-Puerta, M.D., Ph.D., M.P.H., of Brigham and Women's Hospital in Boston, said in a journal news release.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »